The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Miami, FL / Syndication Cloud / January 23, 2026 / Kure Care a division of Veracor Group LLC Key Takeaways Approximately 6.5 to 6.7 million people in the U.S. are affected by chronic wounds each year, ...
A research collaboration led by the Muscular Dystrophy Association (MDA) aims to create a molecular map of human muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results